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Abstract
Background: Tobacco use is the leading preventable cause of death and disease in the United
States, with the prevalence remaining especially high among people with mental illness. Mental
health providers often lack training in smoking cessation and feel uncomfortable addressing the
issue with this patient population. Studies show that educational training offered to providers can
lead to increased knowledge that improves the provider’s confidence and attitude about
delivering smoking cessation treatment to patients. Mental health professionals must receive
training on smoking cessation treatment modalities so they can effectively provide holistic care
needed for recovery for patients with mental illness.
Purpose: The purpose of this DNP project was two-pronged. The first step evaluated the
effectiveness of a web-based simulated smoking-cessation scenario training for mental health
professionals to evaluate if this intervention would promote providers’ intentions to adhere to the
U.S. Preventative Services Task Force (2021) Tobacco Treatment Practice Guideline. The
second step assessed face validity of the video intervention.
Design: A one group pretest-posttest design was conducted at an acute psychiatric hospital to
evaluate the web-based simulated scenario training.
Methods: The web-based simulated scenario had 3 components: 1) A presurvey to assess
knowledge, attitudes, subjective norms, perceived behavioral control and intentions toward
implementing smoking cessation interventions for patients with mental illnesses 2) A 20-minute
video with education on tobacco use and mental illness and a simulated patient-provider
scenario, and 3) A postsurvey to reassess knowledge, and intentions toward implementing
smoking cessation interventions for patients with mental illnesses. In addition, an assessment of
the videos within the training program by field experts was completed to analyze desirability,
applicability, and acceptability.

Results: In the first prong, eighteen participants enrolled and completed the schizophrenia
scenario training (N= 18). Low participation rate in the ADHD scenario led to analysis focused
solely on the schizophrenia scenario. Analysis was conducted on knowledge scores and
intentions to utilize the 5A’s. Knowledge scores significantly improved post-intervention from a
score of 3.0 (0.9) to 4.3 (1.2) with a p-value of 0.005. Intentions to use the 5A’s postintervention was high with a score of 11 (2.5). In the second prong, two experts assessed the
ADHD scenario and two assessed the schizophrenia scenario. For the ADHD video, experts
scored desirability, applicability, and acceptability as most desirable (5). For the schizophrenia
scenario, desirability was 5 for information about tobacco use and schizophrenia and for all 5As,
but 4 for overall use of the information. Applicability was scored 5 for Ask and Assist and 4.5
for Advise, Assess, Arrange, overall use of animation, and information about tobacco use and
schizophrenia. Acceptability was scored 5 for Assist, 4.5 for information about tobacco use and
schizophrenia, Ask, Advise, Assess, and Arrange, and 4 for overall use of animation.
Discussion: In the first prong, presurvey showed a knowledge deficit. Attitudes and intentions
scores were neutral while perceived behavioral control and subjective norms were lower.
Postsurvey showed MHPs gained knowledge and had high intentions to use the 5As suggesting
the intervention may have increased knowledge and intentions to provide treatment based on
USPSTF (2021) guidelines. In the second prong, the ADHD scenario proved to be rated highest
on each category, appearing to have high face validity. In the future, the schizophrenia scenario
may improve with adjustments in animation and language.
Conclusion: Web-based simulated training improved MHPs’ knowledge and intentions of
providing smoking cessation interventions to patients with mental illness. As MHPs gain
knowledge through training programs, dissemination of this knowledge into clinical practice will
enhance the overall mental and physical well-being of patients with mental illness.
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Effectiveness of a Web-Based Smoking Cessation Training Program for Health Care
Professionals within an Acute Psychiatric Facility
Background and Significance
Problem Statement
Mental health professionals (MHPs) often avoid initiating smoking cessation
interventions for their patients admitted to an acute psychiatric hospital despite knowing the
importance of smoking cessation for recovery (Prochaska et al., 2017). The avoidance of
addressing tobacco use in this population continues to lead to disproportionate rate of tobacco
use, related disease, and mortality in this population (Prochaska et al., 2017; CDC, 2019a).
Addressing ways to enhance tobacco treatment delivery by MHPs in the inpatient setting can
support their ability to promote recovery among patients.
Context, Scope and Consequences
Smoking tobacco is the most preventable cause of death and disability in the United
States, contributing to various respiratory, metabolic, cardiovascular diseases, as well as many
other diseases (U.S. Department of Health and Human Services, 2014). Although overall tobacco
use has declined in the last 40 years, the rates have remained unchanged in those with mental
illness (U.S. Department of Health and Human Services, 2014; Cook et al., 2014). According to
the CDC (2019a), patients with mental illness or substance abuse problems typically die 5 years
earlier than the general population due to smoking-related diseases such as cancer, lung disease
and cardiovascular disease. Smoking tobacco is particularly detrimental to patients’ mental
health treatments because the smoke decreases the effectiveness of psychiatric medications
(CDC, 2019a). Due to the lack of smoking cessation interventions, patients with mental illness
are not receiving the highest quality of care, which can contribute to premature death.
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According to Prochaska et al. (2017), the rate of smoking is almost fivefold greater in
people with posttraumatic stress disorder (PTSD), substance abuse disorders, schizophrenia, and
bipolar disorder when compared to the general public. Having multiple mental illnesses is also
associated with an increased smoking prevalence. For example, Prochaska et al. (2017) explains
that 18% of people without any psychiatric condition smoke, compared to 61% of people with 3
or more psychiatric conditions. Smoking is thought to be more prevalent among those with
mental illness as nicotine may temporarily reduce some symptom burden of mental illnesses
(NIDA, 2020). Despite this phenomenon, smoking is associated with worse behavioral and
physical outcomes in people with mental illness (NIDA, 2020). It is also important to note that
smoking-related illnesses cost the US over $300 billion annually (CDC, 2019b). The cost of
health care in the U.S. will continue to rise if providers fail to initiate smoking cessation
interventions for those with mental illness (U.S. Department of Health and Human Services,
2014). Unfortunately, health care professionals still overlook smoking cessation interventions for
those with co-occurring mental illness.
Smoking cessation myths often discourage clinicians from promoting cessation for
patients with mental illness. Common misconceptions about smoking cessation and mental
illness include patients are uninterested in cessation or unable to quit, abstinence interferes with
recovery, smoking is a lesser problem than other substances, and smoking is important for
selfmedication (CDC, 2019a). Time constraints in the clinical setting may also contribute to the
provider’s ability to provide necessary interventions that promote smoking cessation (Gass et al.,
2017). The provider is likely to focus only on the psychiatric symptoms and treatment modalities
within the time constraints, dismissing the issue of smoking cessation.
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Current Evidence-Based Interventions
Providers must be trained on smoking cessation interventions and techniques specific to
patients with mental illness. Rogers et al. (2017) recognized that providers often avoid cessation
topics due to discomfort caused by the lack of training. However, many studies show smoking
cessation training for MHPs lead to increased confidence and knowledge, and improved
attitudes. There have been many effective methods to train providers on smoking cessation
including web-based interventions, in-person seminars, lectures, and courses (Herold et al.,
2016; Rogers et al., 2017). Web-based trainings are shown to be both convenient for MHPs and
effective for practice change (Carpenter et al., 2012; Sarna et al., 2018; Williams et al., 2019;
Hirsch & Nagler, 2020; Hudmon et al., 2021). Based on the evidence, it is important to consider
web-based training as a viable option for training providers in an inpatient psychiatric hospital.
Purpose/Objectives
The purpose of this DNP project was two-pronged. The first prong included an
evaluation of the effectiveness of the University of Kentucky (UK) Behavioral Health and
Wellness Environments for Living and Learning (BH WELL) web-based simulated smoking
cessation training program for MHPs to promote providers’ adherence to the U.S. Preventative
Services Task Force (USPSTF) (2021) tobacco treatment practice guideline. The second prong
was to determine face validity of the educational content performed by experts at the University
of Kentucky. Thus, the specific aims of this DNP project were:
1) To examine the changes in MHPs’ knowledge and intentions toward implementing
smoking cessation interventions in the clinical setting after engaging in an educational
intervention, and
2) To determine the desirability, applicability, and acceptability of the educational videos as
appropriate educational intervention for promoting providers’ adherence to the U.S.
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Preventative Services Task Force (USPSTF) (2021) tobacco treatment practice guideline.
Theoretical Framework
The theoretical framework guiding the smoking cessation web-based training was the
Theory of Planned Behavior (TPB) (Ajzen, 1985). The TPB is a framework which addresses the
psychological factors influencing behavior. The basis of this theory suggests that attitudes (the
positive or negative regard towards a behavior), subjective norms (the behavior is seen as
“normal” or not) and perceived behavioral control (the person believes they can engage in the
behavior or not) predicts a person’s intention to perform a behavior and their intention predicts
follow through with the behavior (Ajzen, 1985). The TPB was most suitable for this project
because it describes how attitudes, subjective norms, and perceived behavioral control may
influence a provider’s intention to provide smoking cessation interventions for those with mental
illness.
In this project, the BH WELL simulated scenario intervention incorporated the constructs
of the TPB to improve MHPs intention to provide smoking cessation interventions for patients
with either ADHD or schizophrenia. Utilizing the simulated scenario trainings, MHPs were
specifically educated on the importance of implementing and instructed on how to implement the
USPSTF (2021) tobacco treatment guidelines. The BH WELL trainings were expected to
increase MHP knowledge of smoking cessation interventions and increase intentions of
providing interventions for patients with mental illness.
Literature Review
The PICOT question guiding the review was, “Can the implementation of a web-based
simulated patient-provider scenario impact the knowledge and intentions of mental health
professionals regarding smoking cessation for patients with mental illness?” In addition, a
secondary literature review was conducted to determine the face validity of the educational video
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intervention; specifically determining the desirability, applicability, and acceptability of the
content of the educational videos.
A literature review was conducted to understand the effectiveness of a web-based
simulated scenario as a tool to improve provider’s knowledge and attitudes regarding smoking
cessation for patients with mental illness. A MESH term search was performed of the PubMed
database, using the following key words and terms: “web-based training” (AND) “tobacco
cessation” which produced 123 articles. Another MESH search was performed of the PubMed
database using the following key words and terms: “video simulation” (AND) “provider
knowledge” (AND) “United States” which produced 43 articles. Lastly, a MESH term search of
the PubMed database was performed using the following key words: “psychiatric providers”
AND “smoking cessation training” AND “practice change” which produced 39 articles. Articles
meeting the inclusion criteria were published from 2011 through present, peer-reviewed, written
in English, and studies conducted in western countries including Australia, USA, Canada, and
the UK. Articles not adhering to the inclusion criteria were excluded for this review.
Ten studies meeting the inclusion/exclusion criteria were retrieved using the key words
and MESH terms. The locations of the studies were within the United States within varied
setting including: a university in southeastern U.S., four healthcare organizations in Washington
State, nurses in Louisiana and Kentucky, a children’s hospital, an emergency department,
respiratory therapists/respiratory care programs, and a psychiatry residency program. All studies
were quasi-experimental with the exception of two mixed methods and one RCT. All the articles
included web-based interventions with 8 studies specifically addressing web-based interventions
on tobacco cessation (Carpenter et al., 2012; Gordon & Mahabee-Gittens, 2011; Sarna et al.,
2018; Williams et al., 2019; Hudmon et al., 2021; Asfar et al., 2018; Rosvall & Carlson, 2017;
Gordon et al., 2013). Only one article addressed educational web-based tobacco cessation
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interventions for behavioral health personnel (Williams et al., 2019). Only two articles addressed
web-based interventions regarding different health care concerns with one focusing on cardiac
material (Herron et al., 2019) and the other on general clinical practice, quality improvement,
facility policies and educational efforts (Hirsch & Nagler, 2020).
A second literature review was conducted to determine face validity of an educational
video. A MESH term search of the PubMed database was performed, using the following key
words and terms: “content analysis” AND “educational videos” AND “smoking” which
produced 29 articles. Another MESH term search of the PubMed database was performed using
the following key words and terms: “content analysis” AND “educational videos” AND
“YouTube” which produced 181 articles. Articles meeting the inclusion criteria were articles
published 2010 through present, peer-reviewed, written in English, and studies conducted in
western countries including Australia, USA, Canada, and the UK. Articles not adhering to the
inclusion criteria were excluded for this review.
Five articles meeting the inclusion/exclusion criteria were chosen from the search
mentioned above to help determine face validity of an educational video. The educational
platforms of the videos analyzed varied slightly. Four articles addressed content from videos
only on YouTube. One article addressed video content from international health organizations
and institutes, as well as verified videos from YouTube. All studies were qualitative studies, and
all were content analyses on educational videos (Ahmad, et al., 2020; Paek et al., 2010; Verma et
al., 2021; Basch et al., 2017; Tolentino, 2016). One article addressed specifically antismoking
educational videos (Paek et al., 2010). The second article addressed educational videos related to
prostate cancer (Basch et al., 2017). The third article addressed medical professionalism in video
(Ahmad et al., 2020). The fourth article addressed videos on instructing English language
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learners (Tolentino, 2016). The last article addressed videos on hand hygiene during the COVID19 pandemic (Verma et al., 2021).
Synthesis
The evidence presented on web-based simulated training was strong because each
individual study had many participants; however, each study may or may not generalize to an
acute psychiatric facility and most of the studies were quasi-experimental with only two mixed
methods and one RCT. The literature review showed that once providers completed the
webbased training and video simulation, they were more confident in their ability to deliver
treatment and education to their clients. In all cases, the web-based training programs led to a
clinical practice change within the health care facility (Carpenter et al., 2012; Sarna et al., 2018;
Williams et al., 2019; Hirsch & Nagler, 2020; Hudmon et al., 2021). The video simulation, in
particular, provided the “real-life” experience that improved the provider’s ability to engage in
the topic, which in turn, decreased the provider’s anxiety about the subject (Herron et al., 2019).
The evidence presented on content analysis was strong with each study analyzing several
different videos. A consistent theme within the content analyses included the importance of
having accurate information provided by professional educators within the subject area (Ahmad,
et al., 2020; Paek et al., 2010; Verma et al., 2021; Basch et al., 2017; Tolentino, 2016). In
addition, a repeated theme noted by the participants was the importance of having the education
program based on practice guidelines for validity or at least having information from reputable
organizations such as WHO, CDC, etc. Another theme from the analyses was the importance of
having high quality videos and audio performance for the ease of viewing. Lastly, educational
videos were found most helpful for visual and auditory learners. For future study, it may be
helpful to create platforms to enhance the educational environment for kinesthetic and
reading/writing learners (Ahmad, et al., 2020; Paek et al., 2010; Verma et al., 2021; Basch et al.,
13

2017; Tolentino, 2016).
Based on the literature, a web-based simulated scenario intervention for MHPs was
expected to improve compliance with the USPSTF (2021) guidelines for behavioral and
pharmacotherapy interventions for tobacco smoking cessation in adults with mental illness. It
was also expected that the assessment form would help determine the desirability, applicability,
and acceptability of the web-based simulated scenario video.
Design
The first prong of this DNP project followed the parent study (Okoli et al., 2022) by
using a one group pretest-posttest design to examine the effect of a web-based simulated
smoking cessation scenario program on knowledge and intentions of MHPs. The educational
training addressed smoking cessation interventions for patients with mental illnesses. The
knowledge, attitudes, subjective norms, perceived behavioral control, and intentions were
assessed before and immediately after participants engaged in the web-based simulated scenario.
The second prong of this DNP project was to assess face validity of the educational
videos to determine their desirability, applicability, and acceptability. Two tobacco cessation
experts were emailed the video link based on a client with ADHD and two tobacco cessation
experts were emailed the video link based on a client with schizophrenia. An assessment form
was sent for the experts to fill out following the video viewing (See Appendix C).
Methods
Setting
Agency Description
This DNP project was implemented at the Ridge Behavioral Health Systems and Eastern State
Hospital in Lexington, KY. The Ridge is a 110-bed hospital providing psychiatric and substance
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use disorder care for adults and adolescents. Eastern State Hospital is a 239-bed state psychiatric
facility.
Sample
For the first prong of this DNP project, a convenience sample of 54 staff participants at
The Ridge and Eastern State Hospital were targeted. At The Ridge, the staff participants on the
adult unit consisted of 8 nurses, 4 prescribers, and 4 social workers. The Ridge pediatric unit
participants consisted of 4 nurses, 4 prescribers, and 4 social workers. Eastern State Hospital
participants consisted of 8 nurses, 6 prescribers, 6 social workers and 6 therapists. Potential
participants were chosen by managers of each discipline. The inclusion criteria for this project
included employees providing direct patient care who were credentialed as registered nurses,
licensed practical nurses, licensed clinical social workers, licensed therapists, medical doctors, or
nurse practitioners. Exclusion criteria for this project included mental health technicians and
administrators who were not providing direct patient care, as well as students, and interns.
For the second prong of this DNP project, a convenience sample of 4 tobacco cessation
experts were chosen who were associated with the University of Kentucky.
Agency Mission and Project Alignment
The Ridge provides responsive and compassionate care to their patients as a core value. They
dedicate themselves to the highest standard of care and ethics and are committed to meeting the
diverse needs of the community. The Ridge provides inpatient care and is managed by Universal
Health Services, Inc. (UHS). The mission of The Ridge is providing quality healthcare services
that promote wellness of individuals and the community (UHS Inc., n.d.).
Eastern State Hospital (ESH) is one of four State psychiatric facilities in Kentucky that is
managed by UKHealthcare. ESH provides recovery-focused inpatient care for acute mental
health conditions in a catchment area of 50 counties surrounding Lexington, KY. Its mission is
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to provide excellent mental healthcare which instills hope, inspires recovery, and enhances
wellbeing for Kentuckians. ESH has adopted DIRCT values of Diversity, Innovation, Respect,
Compassion, and Teamwork (UKHealthCare, n.d.).
To support the missions of these facilities, this project addressed barriers that hinder staff
engagement in smoking cessation interventions. The Ridge and ESH emphasize the importance
of quality mental healthcare delivery that promotes well-being for their patients and for the
community. Implementing smoking cessation interventions for each patient who smokes is vital
for ensuring the utmost care for their patients. This project was expected to increase staff
knowledge and intentions of implementing smoking cessation interventions which aligns well
with both facilities’ missions.
Project Stakeholders
Project stakeholders included the DNP project committee, Dr. Evelyn Parrish, committee
chair, Dr. Karen Butler, committee member, Dr. Chizimuzo Okoli, clinical mentor and Dr.
Amanda Thaxton-Wiggins, the statistician. The Ridge Chief Executive Officer (CEO) and the
Chief Nursing Officer (CNO) agreed to support this project implementation and provided access
to staff involved in completing the data. The Ridge MHPs were main stakeholders as participants
in this project. The Ridge patients and patient families were also stakeholders as the intervention
could increase MHP compliance with USPSTF (2021) tobacco cessation guidelines.
Project stakeholders from Eastern State Hospital include, again, Dr. Chizimuzo Okoli
who is the director of tobacco treatment services and evidence-based practice at ESH and Marc
Woods who serves as the Chief Nursing Officer (CNO) at Eastern State Hospital. These two
individuals provided guidance in the development of the project as well as access to the staff
who were involved in completing the data for the project. MHPs at Eastern State Hospital were
also main stakeholders as participants in this project. ESH patients and patient families were also
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stakeholders as the intervention could increase MHP compliance with USPSTF (2021) tobacco
cessation guidelines.
Facilitators and Barriers
There were several facilitators for completing the project at The Ridge and at ESH.
Facilitators included financial compensation for staff participants, support from the
administration, and technology available for training purposes. Financial compensation came
from the parent study which received funding from Kentucky Department of Public Health.
Barriers included time constraints for staff, high turnover rate of staff participants, and hesitancy
of the staff to buy-in to the training. To overcome these barriers, the principal investigator (PI)
worked closely with administration to ensure there was ample time to complete the training. Due
to the high turnover rate of staff participants, the PI worked closely with administration to seek
out new employees to participate in the project.
Project Intervention
The intervention aligned with evidence found from the review of literature, which
utilized web-based educational simulations to improve knowledge and attitudes of healthcare
workers (Carpenter et al., 2012; Sarna et al., 2018; Williams et al., 2019; Hirsch & Nagler, 2020;
Hudmon et al., 2021). The project intervention was developed as part of this project’s parent
study, which utilized a simulated scenario video developed by experts at University of Kentucky
BH WELL program. The purpose of this project was to demonstrate the effectiveness of the two
web-based simulation scenarios as educational tools for staff.
The first prong of this project included two interventions. One intervention was an
educational video on tobacco use in those with ADHD that also included a simulated scenario
with a provider and a patient with ADHD (BH Well, 2020a). The other intervention was an
educational video on tobacco use in those with schizophrenia that also included a simulated
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scenario with a provider and a patient with schizophrenia (BH Well, 2020b). The project had 3
components including: 1) A presurvey to assess MHPs knowledge, attitudes, subjective norms,
perceived behavioral control, and intentions regarding smoking cessation for patients with
mental illnesses 2) The 20-minute video with education on tobacco use and mental illness and a
simulated patient-provider scenario, and 3) A postsurvey to reassess MHPs knowledge and
intentions regarding smoking cessation interventions for patients with mental illness. It is
anticipated the results of the surveys will help guide further research on improving the training to
further improve care for patients.
For the second prong of this project, two tobacco cessation experts were emailed the
video intervention link based on the client with ADHD and two tobacco cessation experts were
emailed the video intervention link based on a client with schizophrenia. An assessment form
was sent for the experts to fill out following the video in which experts assessed the desirability,
acceptability, and applicability of the intervention (See Appendix C).
Procedure
IRB Approval
Before beginning the project, Institutional Review Board (IRB) approval was obtained
from the University of Kentucky (UK) IRB for the parent study in which this DNP project is a
part. A letter of support was obtained from Nina Eisner, Chief Executive Officer (CEO) of The
Ridge. A letter of support was also obtained from Marc Woods, CNO of Eastern State Hospital.
Methods and Instruments
Web-Based Simulation. Demographic measures included age, race, sex, education,
disciplinary role, time in discipline, patient population served, prior tobacco treatment training
and personal history of and recent tobacco use. Other measures utilized in this project were
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based on TPB constructs and include knowledge, attitudes, intentions, subjective norms, and
perceived behavioral control (Azjen, 1985).
Knowledge On Providing Tobacco Treatment. Knowledge measures were based
on the information provided from the sources in the simulated scenario videos (van Amsterdam
et al., 2018; Goldenson et al., 2018; Dvorsky & Landberg, 2019; Hunter et al., 2020; Scott et al.,
2018; Hu et al., 2018; Smucny & Tregellas, 2017; Lawn & Pols, 2005; Prochaska & YoungWolff, 2017). Knowledge of the harm of tobacco use was assessed using 5 yes/no questions.
Knowledge regarding the most effective methods for cessation support was assessed using a
rating scale with 1 being the least effective and 5 being the most effective. Knowledge on
tobacco use and the specific mental illness was assessed using five T/F questions. Validity and
reliability of this scale was analyzed following the project.
Attitudes Toward Providing Tobacco Treatment. Attitudes regarding tobacco
treatment was assessed with four items on a 7-point Likert scale which were based on TPB
(Azjen, 1991, 2011). In the study by Okoli et al. (2017), a mean score was derived, with the scale
demonstrating acceptable internal consistency (α = .80).
Subjective Norms Regarding Tobacco Treatment. Subjective norms regarding
tobacco treatment was assessed with four items on a 7-point Likert scale which was based on
TPB (Azjen, 1991, 2011). In the study by Okoli et al. (2017), a mean score was derived, and the
scale demonstrated adequate internal consistency (α = .79).
Perceived Behavioral Control in Providing Tobacco Treatment. Perceived
behavioral control in providing tobacco treatment was assessed with 4 items on a 7-point Likert
scale based on TPB (Azjen, 1991, 2011). In the study by Okoli et al. (2017), a mean score was
derived, but the scale did not demonstrate adequate internal consistency (α = .50).
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Intentions of Providing Tobacco Treatment. Intentions to provide tobacco
treatment was measured with 3 items on a 7-point Likert scale which was based on TPB (Azjen,
1991, 2011). In the study by Okoli et al. (2017), a mean score for the scale was derived, and the
scale demonstrated strong internal consistency (α = .92).
Brief Intervention for Tobacco Treatment (5As). The current use of the 5As
(Ask, Advise, Assess, Assist, and Arrange) was assessed prior to the intervention and intention to
use the 5As in the future was assessed following the intervention. The pre and post intervention
evaluation was performed using a five-item measure. Each question was evaluated on a 4-point
Likert scale. A higher score demonstrated performing the 5As more frequently. In the study by
Okoli et al. (2017), the scale demonstrated adequate internal consistency (α = .87).
Face Validity of the Educational Intervention. Field experts rated the video
intervention based on their desirability, applicability, and acceptability. Desirability was defined
as something you would want to hear/learn about, applicability was defined as something that is
useful to you/you could use, and acceptability was defined as something that would gain your
interest/would make you seek more information. Seven individual parts of the video intervention
were ranked on a scale from 0 to 5 (0 being not desirable/applicable/acceptable and 5 being very
desirable/applicable/acceptable). The parts ranked included Part A of the video which included
information on tobacco use and ADHD, Part B of the video which included Ask, Advise, Assess,
Assist, Arrange, and, last, the overall use of animation in the video.
Implementation
Data Collection. Data from the web-based simulation scenario was collected using
Qualtrics, an online survey software. Data collection included a presurvey and postsurvey
administered before and after the educational video intervention. The Qualtrics link was
delivered to MHPs’ managers’ emails. Managers then distributed emails to potential participants.
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The module began with a cover letter with information on the project and on giving consent to
participate, continued to the presurvey, and then continued to the educational video intervention.
Immediately following the intervention, participants responded to the postsurvey.
The data from the Qualtrics survey was protected and stored on a password protected and
firewall protected computer which was linked to the UK server. The survey was anonymous and
only the research team from the parent study had access to the data. Following survey
completion, participants were provided a link to enter their name and email address to receive a
$50 Amazon gift card to compensate for their time. The link was not connected to their survey to
ensure anonymity. All data will be stored for a minimum of 6 years upon completion of the
study.
Data from the experts for face validity was collected via UKY email. The video link and
the face validity form were emailed directly to the experts. Once the experts completed watching
the video and completed the analysis form, the expert participants emailed the analysis form
back for collection.
Data Analysis for Web-Based Simulation. In the data analysis, substitution using
means for continuous variables and modes for nominal variables were used for missing data.
Analyses were conducted using SPSS version 28 and used alpha level 0.05 for statistical
significance. Descriptive statistics included means with SD used for age, frequencies with
percentages used for sex, race, discipline, prior tobacco treatment training, practice setting,
population served, past and recent tobacco use, and median with IQR for time in discipline.
Descriptive statistics (mean [SD] or %) were also used for opinions, effectiveness of cessation
methods, intentions, attitudes, subjective norms, and perceived behavioral control. A paired
sample t-test was used to analyze change in mean knowledge scores and in frequency of using
the 5A’s intervention before and following the educational content.

21

Data Analysis for Face Validity. Face validity of the ADHD and schizophrenia
educational videos was determined by obtaining data from tobacco treatment specialists
represented from nursing and social work at the University of Kentucky (See Appendix C).
Mean scores were calculated for each of the categories (desirability, applicability, and
acceptability) of the educational video components.
Results
Web-Based Simulation
For the first prong of the project, 54 MHPs were invited to participate. Twelve
participants from The Ridge pediatric unit were invited to participate in the ADHD scenario.
Sixteen participants from The Ridge adult unit and 26 participants from ESH were invited to
participate in the schizophrenia scenario. Eighteen participants enrolled in the project (n= 18).
For the ADHD scenario, only two participants began the training and only one participant
finished the training. Due to the low participation rate, this analysis will focus only on the data
collected from the schizophrenia scenario.
Table 1 displays the descriptive statistics of the demographics from the presurvey. The
average age of the participants was 38.89 (8.96) years. Participants reported race included two
(11.1%) Asian/Pacific Islander, three (16.7%) black/non-Hispanic, and 13 (72.2%) white/nonHispanic. All participants were college graduates with 10 (55.6%) from nursing, two (11.1%)
from psychology (MHC, LMHC/LMFT), two (11.1%) from psychology (psych D, PhD), and
four from social work (LSW/LCSW). The median of time spent in their discipline was three
years (1.75-9.25 years). The primary practice setting included 12 (66.7%) from the inpatient
hospital and 6 (33.3%) from the inpatient behavioral health treatment program. The primary
population served by the MHPs included 16 (88.9%) who worked with adults, one (5.6%) who
worked with pediatrics, and one (5.6%) who worked with geriatrics.
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Only one (5.6%) of the MHP participants received previous tobacco cessation treatment training.
The remaining 17 (94.4%) MHP participants had never received previous tobacco cessation
treatment training. There was a wide variety of participants who had prior tobacco use including
five (27.8%) using cigarettes, two (11.1%) using cigarettes and other (vape, e-cigarettes), one
(5.6%) using only vape/e-cigarettes, and 10 (55.6%) never using tobacco products. In the
presurvey, tobacco use in the past month received little feedback with 10 (55.6%) yielding no
response; however, one (5.6%) reported cigarette use, two (11.1%) reported other tobacco
product use, and five (27.8%) reported no use.
Table 2 displays the descriptive summary of the presurvey. All participants
acknowledged the physical health problems, including pregnancy and birth related complications
caused by smoking. Only 16.7% attributed smoking to cause mental illness, 33.3% attributed
smoking to cause substance use disorder, and 22.2% attributed smoking to the improvement of
mental health symptoms. For smoking cessation interventions, participants scored FDA
approved medication as the most effective cessation method receiving a score of 4.06 (0.8) on a
scale from 1-5. Behavioral counseling followed closely at 3.67 (1.14), self-help resources at 2.67
(0.91), Quitlines at 2.39 (0.78), and last cold turkey at 2.22 (1.17). Participants reported their
intention to provide smoking cessation to patients was somewhat neutral at 4.24 (1.41) on a scale
from 17. Attitudes regarding smoking cessation interventions for patients demonstrated a greater
score at 4.96 (0.96). Subjective norms and perceived behavioral control regarding providing
smoking cessation for patients was decreased at 3.75 (1.21) and 3.87 (1.00) respectively.
Table 3 displays knowledge scores presurvey and postsurvey as well as current use of
5As from the presurvey and intention to use the 5As in the future from the postsurvey. The
average knowledge score in the presurvey was 3.0 (0.9) out of 5 questions. Post- intervention,
the mean score increased significantly to 4.3 (1.2) out of 5 questions with a p-value of .005.
Frequency of using the 5A’s, participants received an average score of 8.6 (3.4) presurvey. The
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intended frequency to use the 5A’s was high following the post-intervention with an average
score of 11(2.5).
Face Validity
For the second prong of the project, four tobacco cessation experts at the University of
Kentucky were invited to assess the two interventions for desirability, applicability, and
acceptability. Two experts evaluated the ADHD scenario intervention, and two experts evaluated
the schizophrenia scenario intervention. For the ADHD video, both expert reviewers ranked each
part of the video as most desirable (5), applicable (5) and acceptable (5). Table 4 displays
average expert scores for the ADHD scenario intervention. For the schizophrenia video, the
average reviewer score for desirability was 5 for information about tobacco use and
schizophrenia and for all components of the 5As. The mean score for desirability of overall use
of the information was a 4. The average reviewer score for applicability was 5 for Ask and
Assist. For information about tobacco use and schizophrenia, Advise, Assess, Arrange and
overall use of animation, applicability was scored 4.5 on average. The average reviewer score for
acceptability was 5 for Assist. For information about tobacco use and schizophrenia, Ask,
Advise, Assess, and Arrange, the average score was 4.5 for acceptability. For acceptability of the
overall use of animation, the average score was 4. Table 5 displays the average experts’ scores
for the schizophrenia scenario intervention.
Discussion
Web-Based Simulation
The purpose of the first prong of this project was to evaluate the effectiveness of the
University of Kentucky (UK) BH WELL web-based simulated smoking cessation training
program for MHPs to promote providers’ adherence to the USPSTF (2021) tobacco treatment
practice guideline. There was fair participation rate for the schizophrenia web-based simulation
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intervention but poor participation rate for the ADHD intervention. This allowed only the
schizophrenia intervention data to be analyzed.
In the presurvey, it was necessary to develop an understanding of MHPs baseline
knowledge, attitudes, subjective norms, perceived behavioral control and intentions regarding
smoking cessation for those with mental illness. The pre-survey showed a knowledge deficit
among providers which is reasonable as most providers also reported no prior training on
smoking cessation interventions for patients. All providers acknowledged that smoking causes
many health issues, but there was a knowledge deficit when asked about the impact of smoking
on mental health disorders and substance use disorder. Surprisingly, there was also a small
percentage of providers who felt smoking improved mental health symptoms even though,
ultimately, smoking worsens mental health symptoms and smoking cessation improves mental
health (CDC, 2019a; Taylor et al., 2014; Taylor et al., 2021).
All participants acknowledged different interventions for smoking cessations as effective,
with the majority favoring FDA-approved medication as most effective. This is appropriate
based on USPSTF (2021) recommendations which encourage providers to prescribe
pharmacotherapy for smoking cessation. The intention of MHPs to provide smoking cessation
for patients was somewhat neutral, with their attitudes regarding smoking cessation for patients
to be slightly higher than neutral. Subjective norm and perceived behavioral control regarding
providing smoking cessation for patients was less. This is concerning as some literature suggests
that subjective norms and/or perceived behavioral control is a major predictor in follow through
of implementing a practice change (Shelley et al., 2014; Blankers et al., 2016). Participants also
reported a low use of the 5As with a mean score of 8.6 (3.4) out of 15.
Following the web-based simulated educational video, the providers completed a
postsurvey to assess for knowledge gained and increased intentions of providing the 5As to
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patients. Knowledge mean score increased significantly with a p-value of .005 and the mean
score went from 3.0(0.9) out of 5 to a mean score of 4.3 (1.2) out of 5. The results suggest the
web-based simulation training intervention significantly increased knowledge. There was also a
higher-than-average rating in the intention to utilize the 5As in the future with a postintervention mean score of 11 (2.5) out of 15. The results suggest that the web-based simulation
training may have increased participants’ intention to provide appropriate treatment based on
USPSTF (2021) guidelines. Based on TPB (Ajzen, 1985), it would be expected that there would
be increased follow through on the behavior based on the increased intentions.
Face Validity
The second prong of this project was to determine the face validity of the educational
content which was evaluated by experts at the University of Kentucky. Overall, both scenarios
had high mean ratings on each category including desirability, applicability, and acceptability.
The ADHD scenario had the highest mean scores with each part of the video receiving the
highest score in all 3 categories. The schizophrenia scenario also received high scores in each
category with the lowest score being a 4 out of 5 for desirability and acceptability of the overall
animation of the video. Upon review of the schizophrenia video, there appeared to be a glitch
with the animation in which the voice-over had the incorrect voice and content, which could
have decreased this score. There were several categories in which this video received 4.5 out of 5
and one expert recommended to increase the use of “plain language” rather than medical jargon
when counselling the patient. Secondly, the video mentioned the 2mg nicotine gum for NRT, but
the expert responded that this is under-dosing for a patient with a high level of nicotine
dependence. The findings from this project correlates well with the literature which emphasized
the importance of high-quality videos with accurate information from reliable sources to increase
learning (Ahmad, et al., 2020; Paek et al., 2010; Verma et al., 2021; Basch et al., 2017;
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Tolentino, 2016). To further increase face validity in the schizophrenia video, it may be helpful
to adjust the video’s animation, increase the use of “plain language” and to ensure the highest
quality and most up to date medical information is included in the video.
Implications
The results of this project revealed that MHPs are underprepared for regularly engaging
in smoking cessation interventions for patients with mental illness based on the USPSTF (2021)
guidelines. Web-based trainings are a convenient, effective, and cost-effective way of training
employees. Based on this project, it is clear that implementing a web-based simulated scenario
training is plausible and significantly improves employee’s knowledge and intention to
implement proper practices for smoking cessation. However, it remains unclear if all MHPs
would engage in this type of training program and whether this intervention increases MHPs’ use
of the USPSTF (2021) guidelines over time. It is crucial to continue research on sustaining the
practice of providing smoking cessation interventions to patients with mental illness to ensure
improved behavioral and physical outcomes.
Another important issue noted was the decreased subjective norms and perceived
behavioral control of the MHPs in this project. Based on these two categories, MHPs do not feel
positive peer pressure to engage in smoking cessation interventions with patients nor do they feel
they have control to implement the interventions. Further research may be needed to understand
how to increase both categories to promote the use of USPSTF (2021) guidelines regarding
smoking cessation interventions for patients with mental illness.
Limitations
Limitations of this project included a small sample size with low participation rate
especially for the ADHD scenario. MHP managers were asked to disperse emails to potential
participants to provide better anonymity for the participants. However, this may have caused
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issues regarding participation rate as we cannot be sure managers dispersed the emails to
potential participants. Another issue influencing response rates could have been lack of time for
MHPs to complete the training and surveys. Managers may have sent emails to participants work
emails and participants chose not to or did not know how to forward this email to their personal
emails to be able to complete after work hours. Important to note is one facility experienced a
high turnover rate of employees with many new managers and other administration which made
it difficult to engage participants in the project. Other limitations impacting participation among
MHPs could have been disinterest in the topic, so they chose not to participate or some MHPs
may have been uncomfortable with technology and declined to participate.
A key limitation of the face validity analysis for each video was the small sample size
which was not randomized. Therefore, the findings may not generalize to other providers or
facilities and the video may not be as effective in carrying out the aims as the results seem.
Conclusion
Smoking is more common in patients with mental illness compared to the general public
and leads to worsened behavioral and physical outcomes. MHPs often do not perform proper
smoking cessation interventions based on the USPSTF (2021) guidelines. Training is important
to increase knowledge and intentions of providing smoking cessation interventions to patients.
Based on the results, the web-based simulation scenario intervention by BH WELL increased
MHP knowledge and intentions regarding smoking cessation interventions for patients with
mental illness.
As intentions and knowledge increase for MHPs, based on Ajzen (1985) TPB, followthrough in providing smoking cessation interventions should increase. Ultimately, as more
MHPs engage in training and in implementing smoking cessation interventions, patients with
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mental illness will also engage in smoking cessation, improving their overall physical and mental
well-being.
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List of Tables
Table 1. Descriptive summary of mental health professionals (N =18)
Mean (SD), Median (IQR) or n (%)
Age
38.89 (8.96)
Sex
Female
12 (66.7%)
Male
6 (33.3%)
College Graduate
18 (100%)
Ethnicity/Race
Asian/Pacific Islander
2 (11.1%)
Black/Non-Hispanic
3 (16.7%)
White/Non-Hispanic
13 (72.2%)
Discipline
Nurse (e.g. LPN/RN)
10 (55.6%)
Psychologist (e.g. MHC, LMHC/LMFT)
2 (11.1%)
Psychologist (e.g. Psych D, PhD)
2 (11.1%)
Social Worker (e.g. LSW/LCSW)
4 (22.2%)
Prior Tobacco Treatment Training
Yes
1 (5.6%)
No
17 (94.4%)
Primary Practice Setting
Inpatient Hospital
12 (66.7%)
Inpatient Behavioral Health Treatment
6 (33.3%)
Program
Primary Population Served
Adults
16 (88.9%)
Pediatrics
1 (5.6%)
Geriatrics
1 (5.6%)
Time in Discipline (years)
3 (1.75-9.25)
Prior Tobacco Use
Cigarettes
5 (27.8%)
Cigarettes and Other (i.e. vape/e2 (11.1%)
cigarettes) Other Tobacco Products Only
1 (5.6%)
(vape/ecigarette) No Use
10 (55.6%)
Tobacco Use in Past Month
Cigarettes
Other Tobacco Products
None
No response

1 (5.6%)
2 (11.1%)
5 (27.8%)
10 (55.6%)
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Table 2. Descriptive summary of knowledge and attitudes, intentions, attitudes, subjective
norms, and perceived behavioral control (N =18)
mean (SD) or % yes
Knowledge and Attitudes
Smoking causes
Physical health problems
100%
Mental illness
16.7%
Substance use disorder
33.3%
Pregnancy and birth related
100%
complications
22.2%
Improvement in mental health
Effectiveness of cessation methods (1-5)*
Cold Turkey
2.22 (1.17)
2.67 (0.91) 2.39
Self- help resources
(0.78)
(pamphlets/brochures)
3.67 (1.14)
Quitlines
Behavioral Counselling (CBT,
4.06 (0.8)
motivational
.
interviewing)
FDA Approved Medications
Intention (1-7)*
4.24 (1.41)
Attitudes (1-7)*
4.96 (0.96)
Subjective Norms (1-7)*
3.75 (1.21)
Perceived Behavioral Control (1-7)*
3.87 (1.00)
Frequency of 5A’s pre-intervention (0-15)*
8.6 (3.4)
Intended frequency of 5A’s post-intervention
11 (2.5)
(0-15)*
* Note: higher scores indicate greater effectiveness, greater intention, positive attitude, greater
subjective norms, greater frequency.

Table 3. Paired T-Test for pre and post intervention (N=18)
Pre-intervention
Post-intervention
mean (SD)
mean (SD)
Knowledge (0-5)
3.0 (0.9)
4.3 (1.2)
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p
.005

Table 4. Expert Review Scores for ADHD Intervention (N=2)
Desirable Score
Applicable Score
1.
PART
A:
Information about
5
5
tobacco use and
ADHD
2. PART B: Ask
5
5
3. PART B: Advise
5
5
4. PART B: Assess
5
5
5. PART B: Assist
5
5
6. PART B: Arrange 5
5
7. Overall use of the
5
5
animation video
Table 5. Expert Review Scores for Schizophrenia Intervention (N=2)
Desirable Score
Applicable Score
1. PART A:
Information about
5
4.5
tobacco use and
schizophrenia
2. PART B: Ask
5
5
3. PART B: Advise
5
4.5
4. PART B: Assess
5
4.5
5. PART B: Assist
5
5
6. PART B: Arrange 5
4.5
7. Overall use of the
4
4.5
animation video
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Acceptable Score
5
5
5
5
5
5
5

Acceptable Score
4.5
4.5
4.5
4.5
5
4.5
4

Appendix A
ADHD Scenario Survey Cover Letter
Dear Participant,
Researchers at the University of Kentucky are inviting you to take part in a survey to evaluate
the desirability, applicability, and acceptability of simulated substance use treatment scenarios
among providers caring for people with behavioral health problems.
Although you may not get personal benefit from taking part in this evaluation study, your
responses may help us understand more about developing cost-effective and resource efficient
means of training a wider audience of providers in evidence-based substance use treatment. In
addition, the information you provide will help us design tailored evidence-based substance use
treatment interventions for clients with behavioral health problems to reduce the disparity in
substance use and related burden in this vulnerable population. Some volunteers experience
satisfaction from knowing they have contributed to research that may possibly benefit others in
the future.
If you do not want to participate in the evaluation, there are no other choices except not to take
part in the evaluation. The survey will take about 40 minutes to complete. The survey will
include three main sections. First there will be a 5-10 minute section in which your fill out a
presurvey questionnaire regarding your knowledge, views and experiences with providing
tobacco and other substance use treatment. Then you will watch and provide your evaluation of a
20-25 minute video of a scenario on providing evidence-based tobacco and substance use
treatment within a healthcare setting. Finally, you will complete a 5-10 minute post-survey
assessing your knowledge and views on providing tobacco and other substance use treatment
after watching the video. There are no known risks to participating in this evaluation study.
Your response to the survey is anonymous which means no names, IP addresses, email
addresses, or any other identifiable information will be collected with the survey responses. We
will not know which responses are yours if you choose to participate.
We hope to receive completed questionnaires from about 150 providers, so your answers are
important to us. Of course, you have a choice about whether or not to complete the survey, but if
you do participate, you are free to skip any questions or discontinue at any time. You will not be
penalized in any way for skipping or discontinuing the survey.
If you have questions about the study, please feel free to ask; my contact information is given
below.
Thank you in advance for your assistance with this important project.
To ensure your responses will be included, please submit your completed survey by July 31,
2021.
Sincerely,
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Chizimuzo Okoli, PhD, MPH, RN
College of Nursing, University of Kentucky
PHONE: 859-246-8020 or 859-866-8508
E-MAIL: ctokol1@uky.edu
If you have complaints, suggestions, or questions about your rights as a research volunteer,
contact the staff in the University of Kentucky Office of Research Integrity at 859-257-9428 or
toll-free at 1-866-400-9428.

Consent Form
EVALUATING SIMULATION-BASED TOBACCO TREATMENT SCENARIOS IN
BEHAVIORAL HEALTH SETTINGS CONSENT FORM
The purpose of this study is to evaluate the desirability, applicability, and acceptability of
simulated tobacco treatment scenario among providers caring for people with behavioral health
problems. Please review the attached survey cover letter Evaluation survey cover letter for
simulated scenarios.
After reviewing the cover letter, please select below if you would wish to participate in this
evaluation survey or not. If you select “Yes, I would like to participate in this study”, you will be
directed to the rest of the survey. If you select, “No, I would not like to participate at this time,”
the survey will be terminated. Thank you.

o Yes, I would like to participate in this study (1)
o No, I would not like to participate at this time (2)
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Schizophrenia Scenario Survey Cover Letter
Dear Participant,
Researchers at the University of Kentucky are inviting you to take part in a survey to evaluate
the desirability, applicability, and acceptability of simulated substance use treatment scenarios
among providers caring for people with behavioral health problems.
Although you may not get personal benefit from taking part in this evaluation study, your
responses may help us understand more about developing cost-effective and resource efficient
means of training a wider audience of providers in evidence-based substance use treatment. In
addition, the information you provide will help us design tailored evidence-based substance use
treatment interventions for clients with behavioral health problems to reduce the disparity in
substance use and related burden in this vulnerable population. Some volunteers experience
satisfaction from knowing they have contributed to research that may possibly benefit others in
the future.
If you do not want to participate in the evaluation, there are no other choices except not to take
part in the evaluation. The survey will take about 45 minutes to complete. First, you will be
provided with a consent form describing the project. Second, if you agree to participate in the
evaluation, you will be directed to a pre-survey questionnaire that will take about 5-10 minutes
to obtain information on your knowledge, views and experiences with providing tobacco and
other substance use treatment. Third, for 20-25 minutes, you will watch and evaluate a video of a
scenario on providing evidence-based tobacco and substance use treatment within a healthcare
setting. Fourth, you will complete a final 5-10 minute post-survey assessing your knowledge and
views on providing tobacco and other substance use treatment after watching the video. After
completing the post-survey questionnaire, you will be directed to click on a link to another site to
provide your name and email address to receive a $ 50 Amazon gift card. You will be qualified
for the gift card by getting to the end of the survey. With a few exceptions, study payments are
considered taxable income reportable to the Internal Revenue Service (IRS). A form 1099 will be
sent to you if your total payments for research participation are $600 or more in a calendar year.
The risks to participating in this survey are minimal, however, because you will be providing
your name and email address to receive $ 50 Amazon gift card, there is a risk for breach of
confidentiality.
Your responses are anonymous which means no names, IP addresses, email addresses, or any
other identifiable information will be linked with your survey responses. We will not know
which responses are yours if you choose to participate.
We hope to receive completed questionnaires from about 150 providers, so your answers are
important to us. Of course, you have a choice about whether or not to complete the survey, but if
you do, you are free to skip any questions or discontinue at any time. You will not be penalized
in any way for skipping or discontinuing the survey.
Please be aware, while we make every effort to safeguard your data, once received from the
online survey company, given the nature of online surveys, as with anything involving the
Internet, we can never guarantee the confidentiality of the data while still on the survey
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company’s servers, or while en route to either them or us. It is also possible that the raw data
collected for research purposes will be used for marketing or reporting purposes by the
survey/data gathering company after the research is concluded, depending on the company’s
Terms of Service and Privacy policies.
If you have questions about the study, please feel free to ask; my contact information is given
below.
Thank you in advance for your assistance with this important project.
To ensure your responses will be included, please submit your completed survey by July 31,
2021.
Sincerely,
Chizimuzo Okoli, PhD, MPH, RN
College of Nursing, University of Kentucky
PHONE: 859-246-8020 or 859-866-8508
E-MAIL: ctokol1@uky.edu
If you have complaints, suggestions, or questions about your rights as a research volunteer,
contact the staff in the University of Kentucky Office of Research Integrity at 859-257-9428 or
toll-free at 1-866-400-9428.
Now that you have reviewed the cover letter, please select below if you would wish to
participate in this evaluation survey or not. If you select “Yes, I would like to participate in this
study”, you will be directed to the rest of the survey. If you select, “No, I would not like to
participate at this time,” the survey will be terminated. Thank you.

o Yes, I would like to participate in this study (1)
o No, I would not like to participate at this time (2)
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Appendix B
ADHD Survey
PRE-TEST SURVEY

SECTION A: DEMOGRAPHICS

A 1. What year were you born?
________________________________________________________________

A 2. Are you?

o Male (1)
o Female (2)
A 3. What is the highest grade or year of school you completed?

o Less than High School (1)
o High School Graduate or GED (2)
o Some College/ vocational/ trade school degree (3)
o College Graduate (4)
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A 4. What is your ethnicity/ race?

o White Non-Hispanic (1)
o Black, Non-Hispanic (2)
o Hispanic (3)
o Asian/ Pacific Islander (4)
o Other (Please Specify) (5) ________________________________________________
A 5. What is your disciplinary background or job role? Are you a:

o Physician/ Psychiatrist (1)
o Advanced Practice Nurse (2)
o Nurse (e.g. LPN/ RN) (3)
o Psychologist (e.g. MHC, LMHC/ LMFT) (4)
o Psychologist (e.g. Psych D, PhD) (5)
o Social Worker (e.g. LSW/ LCSW) (6)
o Other (Please Specify) (7) ________________________________________________
A 6. Have you ever completed tobacco treatment training?

o Yes (1)
o No (2)
If Yes, What type of training have you completed?
________________________________________________________________
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A 7. What is your primary practice setting?

o A Community Mental Health Center (1)
o Outpatient Behavioral Health Treatment Program (2)
o Inpatient Behavioral Health Treatment Program (3)
o An Inpatient Hospital (4)
o Other (Please Specify) (5) ________________________________________________
A 8. Which type of patients/ clients do you serve for more than 50% of your practice?

o Adults (1)
o Pediatrics (children and adolescents) (2)
o Women Only (3)
o Other (Please Specify) (4) ________________________________________________
A 9. For how many years/ months have you worked in your discipline? (Please type in below)

▢
▢

Years (1) ________________________________________________
Months (2) ________________________________________________

45

SECTION B: TOBACCO USE BEHAVIOR
In this section, we are interested in knowing about your tobacco use behavior

B 1 Have you ever used any tobacco products (including vapes or e-cigarettes)?

o Yes, cigarettes (1)
o Yes, tobacco products (including vapes/ e-cigarettes) other than cigarettes (2)
o Yes, cigarettes and other tobacco products (including vapes/ e-cigarettes) (3)
o No (4)
B 2 Have you used any tobacco products (including vapes or e-cigarettes) at least once in the
past month?

o Yes, I have used cigarettes at least once in the past month (1)
o Yes, I have used tobacco products (including vapes/ e-cigarettes) other than cigarettes at
least once in the past month (2)

o Yes, I have used cigarettes and other tobacco products (including vapes/ e-cigarettes) at
least once in the past month (3)

o No (4)
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SECTION C: KNOWLEDGE AND ATTITUDE QUESTIONS
C 1. In your opinion, does smoking or tobacco use...
Yes (1)

No (2)

a. Cause physical health
problems (e.g. Cancer, Heart
disease, lung disease)? (1)

o

o

b. Cause mental illness
(Depressive disorders,
schizophrenia, anxiety, ADHD,
etc.)? (2)

o

o

c. Cause substance use disorder
(alcohol, opioids, marijuana,
other drugs)? (3)

o

o

d. Cause pregnancy and birth
related complications (e.g.
premature birth, pre-eclampsia,
low birth weight)? (4)

o

o

e. Improve mental health
symptoms? (5)

o

o

C 2. Please rate on a scale of 1 to 5 with “1” being the least effective to “5” being the most
effective the following methods to help people stop smoking or using tobacco.
______ a. Cold Turkey (1)
______ b. Self-help resources (e.g. pamphlets, brochures) (2)
______ c. Quitlines (3)
______ d. Behavioral Counseling (e.g. cognitive behavioral therapy, motivational interviewing)
(4)
______ e. FDA approved medications (nicotine replacement products, varenicline, bupropion)
(5)
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C 3.
Attention Deficit Hyperactivity Disorder (ADHD):
Please answer the following questions about ADHD and tobacco use.
True (1)

False (2)

a. Youth with ADHD are at a
higher risk for using tobacco as
compared to youth without
ADHD. (1)

o

o

b. Encouraging youth who use
tobacco products to stop their
use can make their ADHD
symptoms even worse. (2)

o

o

c. Electronic cigarettes (e.g.,
Juuls) and other electronic
tobacco delivery devices contain
water vapor which is essentially
harmless. (3)

o

o

d. There is sufficient evidence to
suggest the use of nicotine patch
and other nicotine replacement
products to help youth who use
tobacco products to quit. (4)

o

o

e. Because of the delivery
system of electronic cigarettes
systems, they are less addictive
than regular cigarettes. (5)

o

o

SECTION D: INTENTIONS, ATTITUDES, SOCIAL NORMS AND PERCEIVED
BEHAVIORAL CONTROL
We would like to know some of your thoughts about providing tobacco treatment.
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D 1.
INTENTION
Indicate to what extent you agree or disagree with the following questions on a scale of 1 to 7
with 1 being 'strongly disagree' and 7 being 'strongly agree'.
1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

7 (7)

1. I expect
to provide
smoking/
tobacco
use
cessation
to
patients/
clients in
the next
six
months.
(1)

o

o

o

o

o

o

o

2. I want
to provide
smoking/
tobacco
use
cessation
to
patients/
clients in
the next
six
months.
(2)

o

o

o

o

o

o

o

3. I intend
to provide
smoking/
tobacco
use
cessation
to
patients/
clients in
the next
six
months.
(3)

o

o

o

o

o

o

o
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D 2. ATTITUDE
1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

7 (7)

1. On a scale of 1 being
‘harmful’ and 7 being
‘beneficial’ how would
you rate providing
smoking/tobacco use
cessation to
patients/clients who
smoke/use tobacco (1)

o o

o

o

o

o

o

2. On a scale of 1 being
‘bad’ and 7 being
‘good’ how would you
rate providing
smoking/tobacco use
cessation to
patients/clients who
smoke/use tobacco. (2)

o o

o

o

o

o

o

3. On a scale of 1 being
‘unpleasant for you’
and 7 being ‘pleasant
for you’ how would
you rate providing
smoking/tobacco use
cessation to
patients/clients who
smoke/use tobacco. (3)

o o

o

o

o

o

o

o o

o

o

o

o

o

4. On a scale of 1 being
‘worthless’ and 7 being
‘useful’ how would
you rate providing
smoking/tobacco use
cessation to
patients/clients who
smoke/use tobacco. (4)
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D 3. SUBJECTIVE NORMS
On a scale of 1 being ‘strongly disagree’ and 7 being ‘strongly agree’ please respond to the
following questions:
1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

7 (7)

1.People who are
important to
me want me to
provide
smoking/tobacco
use cessation to
my
patients/clients
who smoke/use
tobacco (1)

o

o

o

o

o

o

o

2. It is expected
of me that I
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (2)

o

o

o

o

o

o

o

3. I feel under
social pressure to
provide
smoking/tobacco
use cessation to
patients/ clients
who smoke/use
tobacco. (3)

o

o

o

o

o

o

o

4.Most of my
peers think it is
important to
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco (4)

o

o

o

o

o

o

o
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D 4.
PERCEIVED BEHAVIORAL CONTROL
On a scale of 1 being ‘strongly disagree’ and 7 being ‘strongly agree’ please rate your
response to the following statements:
1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

7 (7)

1. I am confident
that I could
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (1)

o

o

o

o

o

o

o

2. For me to
provide
smoking/
tobacco use
cessation to
patients/ clients
who smoke is
easy (2)

o

o

o

o

o

o

o

3.I am able to
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (3)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

4. Whether I
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco is
entirely up to me.
(4)
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SECTION E: 5 A's IN PRACTICE/ ROLE

E1
Please indicate how often you do the following activities based on the following scale: 0= Never
1= Seldom
2= Occasionally
3= Very Often
In your practice role, how often do you
0 (1)

1 (2)

2 (3)

3 (4)

1. ASK
patients/clients
whether they
smoke cigarettes or
use other
tobacco products?
(1)

o

o

o

o

2. ADVISE
patients/clients
who smoke or use
tobacco products to
quit? (2)

o

o

o

o

3. ASSESS the
readiness of
patients/clients
who smoke or use
other tobacco
products to quit or
cut down? (3)

o

o

o

o

4. ASSIST
patients/ clients in
stopping
smoking/tobacco
use by providing
medications and/ or
counseling? (4)

o

o

o

o

53

5. ARRANGE for
patients/ clients to
be referred to
smoking/ tobacco
use cessation
services or follow
up with them on
their abstinence?
(5)

o

o

o

o

End of Block: PRE-TEST SURVEY
Start of Block: SIMULATED SCENARIO VIDEO EVALUATION

SCENARIO VIDEO

We would like your opinions about this video we have developed to train providers on
evidencebased tobacco treatment tailored to a patient/client living with ADHD. We would like
you to rank the video on a scale of 0 to 5, based on how much you see it as desirable, applicable,
and acceptable to you and other providers caring for people with ADHD.
Desirable = something you would want to hear/learn about
Applicable = something that is useful to you/you could use
Acceptable = something that would gain your interest/would make you seek more information.
Please watch the video:

SCENARIO EVALUATION

Please rate the different parts of the video that you just watched on aspects of desirability,
applicability and acceptability. Please use a scale of 0 to 5 (0 being 'not desirable/ applicable/
acceptable' to 5 being 'very desirable/ applicable/ acceptable'. For example, it is possible that you
believe that the video is very desirable and rate it a '5', but you think it is not as applicable to you
and rate it a '2' but that it would be acceptable to your peers and rate it a '4'.
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Desirable Score (1)

Applicable Score (2)

1. PART A:
Information about
tobacco use and ADHD
(1)

2. PART B: Ask (2)

3. PART B: Advise (3)

4. PART B: Assess (4)

5. PART B: Assist (5)

6. PART B: Arrange
(6)

7. Overall use of the
animation video (7)

End of Block: SIMULATED SCENARIO VIDEO EVALUATION
Start of Block: POST-TEST SURVEY
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Acceptable Score (3)

POST-TEST SURVEY
Now that you have watched the videos we would like to wrap up with a few questions about your
knowledge and attitudes about tobacco use among people with ADHD. Please answer the
following questions.

1. In your opinion, does smoking or tobacco use….
Yes (1)

No (2)

a. Cause physical health
problems (e.g. Cancer, Heart
disease, lung disease)? (1)

o

o

b. Cause mental illness
(Depressive disorders,
schizophrenia, anxiety, ADHD
etc.)? (2)

o

o

c. Cause substance use disorder
(alcohol use, opioid use,
marijuana use, other drug use)?
(4)

o

o

o

o

o

o

d. Cause pregnancy and birth
related complications (e.g.
premature birth, pre-eclampsia,
low birth weight)? (5)
e. Improve mental health
symptoms? (6)
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2. Please rate on a scale of 1 to 5 with “1” being not at all effective to “5” being very effective
the following methods to help people stop smoking or using tobacco.
1 (1)
a. Cold Turkey
(1)

2 (2)

3 (3)

4 (4)

5 (5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

d. Behavioral
Counseling
(e.g. cognitive
behavioral
therapy,
motivational
interviewing)
(4)

o

o

o

o

o

e. FDA
approved
medications
(nicotine
replacement
products,
varenicline,
bupropion) (5)

o

o

o

o

o

b. Self-help
resources (e.g.
pamphlets,
brochures) (2)
c. Quitlines (3)
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3. Attention Deficit Hyperactivity Disorder (ADHD):
Please answer the following questions about ADHD and tobacco use.
True (1)

False (2)

a. Youth with ADHD are
equally as likely to use tobacco
as compared to youth without
ADHD. (1)

o

o

b. Encouraging youth who use
tobacco products to stop their
use can make their ADHD
symptoms even worse. (2)

o

o

c. Electronic cigarettes (e.g.,
Juuls) and other electronic
tobacco delivery devices contain
water vapor which is essentially
harmless. (3)

o

o

d. There is sufficient evidence to
suggest the use of nicotine patch
and other nicotine replacement
products to help youth who use
tobacco products to quit. (4)

o

o

e. Because of the delivery
system of electronic cigarettes
systems, they are less addictive
than regular cigarettes. (5)

o

o

4. Please indicate your response on the following scale:
0= Never
1= Seldom
2= Occasionally
often do you anticipate that you will
0 (1)
1. ASK patients/
clients whether
they smoke
cigarettes or use
other tobacco
products? (1)

o

1 (2)

o
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3= Very Often In your practice role, how
2 (3)

o

3 (4)

o

2. ADVISE
patients/clients
who smoke or use
tobacco products to
quit? (2)

o

o

o

o

3. ASSESS the
readiness of
patients/clients
who smoke or use
other tobacco
products to quit or
cut down? (3)

o

o

o

o

4. ASSIST
patients/ clients in
stopping smoking/
tobacco use by
providing
medications and/ or
counseling? (4)

o

o

o

o

o

o

o

o

5. ARRANGE for
patients/clients to
be referred to
smoking/ tobacco
use cessation
services or follow
up with them on
their abstinence?
(5)
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Schizophrenia Survey
PRE-TEST SURVEY

SECTION A: DEMOGRAPHIC INFORMATION

A 1. What year were you born?
________________________________________________________________

A 2. Are you?

o Male (1)
o Female (2)
A 3. What is the highest grade or year of school you completed?

o Less than High School (1)
o High School Graduate or GED (2)
o Some College/ vocational/ trade school degree (3)
o College Graduate (4)
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A 4. What is your ethnicity/ race?

o White Non-Hispanic (1)
o Black, Non-Hispanic (2)
o Hispanic (3)
o Asian/ Pacific Islander (4)
o Other (Please Specify) (5) ________________________________________________
A 5. What is your disciplinary background or job role? Are you a:

o Physician/ Psychiatrist (1)
o Advanced Practice Nurse (2)
o Nurse (e.g. LPN/ RN) (3)
o Psychologist (e.g. MHC, LMHC/ LMFT) (4)
o Psychologist (e.g. Psych D, PhD) (5)
o Social Worker (e.g. LSW/ LCSW) (6)
o Other (Please Specify) (7) ________________________________________________
A 6. Have you ever completed tobacco treatment training?

o Yes (1)
o No (2)
If Yes, What type of training have you completed?
________________________________________________________________
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A 7. What is your primary practice setting?

o A Community Mental Health Center (1)
o Outpatient Behavioral Health Treatment Program (2)
o Inpatient Behavioral Health Treatment Program (3)
o An Inpatient Hospital (4)
o Other (Please Specify) (5) ________________________________________________
A 8. Which type of patients/ clients do you serve for more than 50% of your practice?

o Adults (1)
o Pediatrics (Child and adolescents) (2)
o Women Only (3)
o Other (Please Specify) (4) ________________________________________________
A 9. For how many years/ months have you worked in your discipline? (Please type in below)

▢
▢

Years (1) ________________________________________________
Months (2) ________________________________________________

Page Break
SECTION B: TOBACCO USE BEHAVIOR

In this section, we are interested in knowing about your tobacco use behavior
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B 1 Have you ever used any tobacco products (including vapes or e-cigarettes)?

o Yes, cigarettes (1)
o Yes, tobacco products (including vapes/ e-cigarettes) other than cigarettes (2)
o Yes, cigarettes and other tobacco products (including vapes/ e-cigarettes) (3)
o No (4)
B 2 Have you used any tobacco products (including vapes or e-cigarettes) at least once in the
past month?

o Yes, I have used cigarettes at least once in the past month (1)
o Yes, I have used tobacco products (including vapes/ e-cigarettes) other than cigarettes at
least once in the past month (2)

o Yes, I have used cigarettes and other tobacco products (including vapes/ e-cigarettes) at
least once in the past month (3)

o No (4)
Page Break
SECTION C: KNOWLEDGE AND ATTITUDE QUESTIONS
C 1. In your opinion, does smoking or tobacco use...
Yes (1)

No (2)

a. Cause physical health
problems (e.g., cancer, heart
disease, lung disease)? (1)

o

o

b. Cause mental illness
(Depressive disorders,
schizophrenia, anxiety, ADHD
e.t.c)? (2)

o

o

c. Cause substance use disorder
(alcohol use, opioid use,
marijuana use, other drug use)?
(3)

o

o
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d. Cause pregnancy and birth
related complications (e.g.
premature birth, pre-eclampsia,
low birth weight)? (4)
e. Improve mental health
symptoms? (5)

o

o

o

o

c 2. Please rate on a scale of 1 to 5 with "1" being the least effective to "5" being the most
effective the following methods to help people stop smoking or using tobacco.
1 (1)
a. Cold Turkey
(1)

2 (2)

3 (3)

4 (4)

5 (5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

d. Behavioral
Counseling
(e.g. cognitive
behavioral
therapy,
motivational
interviewing)
(4)

o

o

o

o

o

e. FDA
approved
medications
(nicotine
replacement
products,
varenicline,
bupropion) (5)

o

o

o

o

o

b. Self-help
resources (e.g.
pamphlets,
brochures) (2)
c. Quitlines (3)
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C 3.
Schizophrenia:
Please answer the following questions about Schizophrenia and tobacco use.
True (1)

False (2)

a. People with schizophrenia are
equally as likely to use tobacco
as compared to the general
population (1)

o

o

b. Nicotine from tobacco use
causes stress for people with
schizophrenia (2)

o

o

c. People with schizophrenia are
more likely to use tobacco
because of permissive attitudes
of providers to tobacco use
within behavioral health settings
(3)

o

o

d. People with schizophrenia are
unable to stop using tobacco
because no evidence exists in
ways to help them (4)

o

o

e. Tobacco use can reduce the
effectiveness of medications
used to treat schizophrenia (5)

o

o

Page Break
SECTION D: INTENTIONS, ATTITUDES, SOCIAL NORMS AND PERCEIVED
BEHAVIORAL CONTROL
The following items are related to providing tobacco treatment.
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D 1.
INTENTION
Indicate to what extent you agree or disagree with the following questions on a scale of 1 to 7
with 1 being 'strongly disagree' and 7 being 'strongly agree'.
1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

7 (7)

1. I expect
to provide
smoking/
tobacco
use
cessation
to
patients/
clients in
the next
six
months.
(1)

o

o

o

o

o

o

o

2. I want
to provide
smoking/
tobacco
use
cessation
to
patients/
clients in
the next
six
months.
(2)

o

o

o

o

o

o

o

3. I intend
to provide
smoking/
tobacco
use
cessation
to
patients/
clients in
the next
six
months.
(3)

o

o

o

o

o

o

o
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D 2. ATTITUDE
1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

7 (7)

1. On a scale of 1
being ‘harmful’
and 7 being
‘beneficial’ how
would you rate
providing
smoking/tobacco
use cessation to
patients/clients
who smoke/ use
tobacco (1)

o

o

o

o

o

o

o

2. On a scale of 1
being ‘bad’ and 7
being ‘good’ how
would you rate
providing
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (2)

o

o

o

o

o

o

o

3. On a scale of 1
being ‘unpleasant
for you’ and 7
being ‘pleasant for
you’ how would
you rate providing
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (3)

o

o

o

o

o

o

o

4. On a scale of 1
being ‘worthless’
and 7 being
‘useful’ how would
you rate providing
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (4)

o

o

o

o

o

o

o
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D 3. SUBJECTIVE NORMS
On a scale of 1 being ‘strongly disagree’ and 7 being ‘strongly agree’ please respond to the
following questions:
1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

7 (7)

1.People who are
important to
me want me to
provide
smoking/tobacco
use cessation to
my
patients/clients
who smoke/use
tobacco (1)

o

o

o

o

o

o

o

2. It is expected
of me that I
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (2)

o

o

o

o

o

o

o

3. I feel under
social pressure to
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (3)

o

o

o

o

o

o

o

4.Most of my
peers think it is
important to
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco (4)

o

o

o

o

o

o

o
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D 4.
PERCEIVED BEHAVIORAL CONTROL
On a scale of 1 being ‘strongly disagree’ and 7 being ‘strongly agree’ please rate your
response to the following statements:
1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

7 (7)

1. I am confident
that I could
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (1)

o

o

o

o

o

o

o

2. For me to
provide
smoking/
tobacco use
cessation to
patients/ clients
who smoke is
easy. (2)

o

o

o

o

o

o

o

3. I am able to
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco. (3)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

4. Whether I
provide
smoking/tobacco
use cessation to
patients/clients
who smoke/use
tobacco is
entirely up to me.
(4)

Page Break
SECTION E: 5 A's IN PRACTICE/ ROLE
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E1
Please indicate how often you do the following activities based on the following scale:

0= Never

1= Seldom

2= Occasionally

3= Very Often

In your practice role, how often do you
0 (1)

1 (2)

2 (3)

3 (4)

1. ASK
patients/clients
whether they smoke
cigarettes or use
other tobacco
products? (1)

o

o

o

o

2. ADVISE
patients/clients who
smoke or use tobacco
products to quit? (2)

o

o

o

o

3. ASSESS the
readiness of
patients/clients who
smoke or use other
tobacco products to
quit or cut down? (3)

o

o

o

o

4. ASSIST
patients/clients in
stopping smoking/
tobacco use by
providing
medications and/ or
counseling? (4)

o

o

o

o

5. ARRANGE for
patients/clients to be
referred to smoking/
tobacco use cessation
services or follow up
with them on their
abstinence? (5)

o

o

o

o

End of Block: PRE-TEST SURVEY
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Start of Block: SIMULATED SCENARIO VIDEO EVALUATION

SCENARIO VIDEO

We would like your opinions about this video we have developed to train providers on
evidencebased tobacco treatment tailored to a patient/client living with schizophrenia. We would
like you to rank the video on a scale of 0 to 5, based on how much you see it as desirable,
applicable, and acceptable to you and other providers caring for people with schizophrenia.
Desirable = something you would want to hear/learn about
Applicable = something that is useful to you/you could use
Acceptable = something that would gain your interest/would make you seek more information.
Please watch the video:

SCENARIO EVALUATION

Please rate the different parts of the video that you just watched on aspects of desirability,
applicability and acceptability. Please use a scale of 0 to 5 (0 being 'not desirable/ applicable/
acceptable' to 5 being 'very desirable/ applicable/ acceptable'. For example, it is possible that you
believe that the video is very desirable and rate it a '5', but you think it is not as applicable to you
and rate it a '2' but that it would be acceptable to your peers and rate it a '4'.
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Desirable Score (1)

Applicable Score (2)

1. PART A:
Information about
tobacco use and
schizophrenia (1)

2. PART B: Ask (2)

3. PART B: Advise (3)

4. PART B: Assess (4)

5. PART B: Assist (5)

6. PART B: Arrange
(6)

7. Overall use of the
animation video (7)

End of Block: SIMULATED SCENARIO VIDEO EVALUATION
Start of Block: POST-TEST SURVEY

72

Acceptable Score (3)

POST-TEST SURVEY
Now that you have watched the videos we would like to wrap up with a few questions about your
knowledge and attitudes about tobacco use among people with schizophrenia. Please answer the
following questions.

1. In your opinion, does smoking or tobacco use….
Yes (1)

No (2)

a. Cause physical health
problems (e.g. Cancer, Heart
disease, lung disease)? (1)

o

o

b. Cause mental illness
(Depressive disorders,
schizophrenia, anxiety, ADHD
etc.)? (2)

o

o

c. Cause substance use disorder
(alcohol use, opioid use,
marijuana use, other drug use)?
(4)

o

o

o

o

o

o

d. Cause pregnancy and birth
related complications (e.g.
premature birth, pre-eclampsia,
low birth weight)? (5)
e. Improve mental health
symptoms? (6)
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2. Please rate on a scale of 1 to 5 with “1” being the least effective to “5” being the most
effective the following methods to help people stop smoking or using tobacco.
1 (1)
a. Cold Turkey
(1)

2 (2)

3 (3)

4 (4)

5 (5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

d. Behavioral
Counseling
(e.g. cognitive
behavioral
therapy,
motivational
interviewing)
(4)

o

o

o

o

o

e. FDA
approved
medications
(nicotine
replacement
products,
varenicline,
bupropion) (5)

o

o

o

o

o

b. Self-help
resources (e.g.
pamphlets,
brochures) (2)
c. Quitlines (3)
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3. Schizophrenia:
Please answer the following questions about schizophrenia and tobacco use.
True (1)

False (2)

a. People with schizophrenia are
equally as likely to use tobacco
as compared to the general
population (1)

o

o

b. Nicotine from tobacco use is
not addictive and causes
agitation for people with
schizophrenia (2)

o

o

c. People with schizophrenia are
more likely to use tobacco
because of permissive attitudes
of providers to tobacco use
within behavioral health settings
(3)

o

o

d. People with schizophrenia are
unable to stop using tobacco
because no evidence exists in
ways to help them (4)

o

o

e. Tobacco use can reduce the
effectiveness of medications
used to treat schizophrenia (5)

o

o

4. Please indicate your response on the following scale:
0= Never

1= Seldom

2= Occasionally

3= Very Often

In your practice role, how often do you anticipate that you will
0 (1)
1. ASK
patients/clients
whether they
smoke cigarettes or
use other
tobacco products?
(1)

o

1 (2)

o
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2 (3)

o

3 (4)

o

2. ADVISE
patients/clients
who smoke or use
tobacco products to
quit? (2)

o

o

o

o

3. ASSESS the
readiness of
patients/clients
who smoke or use
other tobacco
products to quit or
cut down? (3)

o

o

o

o

4. ASSIST
patients/clients in
stopping smoking/
tobacco use by
providing
medications and/ or
counseling? (4)

o

o

o

o

o

o

o

o

5. ARRANGE for
patients/clients to
be referred to
smoking/ tobacco
use cessation
services or follow
up with them on
their abstinence?
(5)

End of Block: POST-TEST SURVEY
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Appendix C
ADHD Face Validity
Dear Participant,

We would like your opinions about this video we have developed to train providers on
evidence-based tobacco treatment tailored to a patient/client living with ADHD. We
would like you to rate the video on a scale of 0 to 5, based on how much you see it as
desirable, applicable, and acceptable to you and other providers caring for people with
ADHD.
Desirable = something you would want to hear/learn about
Applicable = something that is useful to you/you could use
Acceptable = something that would gain your interest/would make you seek more
information.
We would like you to please rate the different parts of the video that you just watched on
aspects of desirability, applicability and acceptability. Please use a scale of 0 to 5
(0 being 'not desirable/applicable/ acceptable' to 5 being 'very desirable/ applicable/
acceptable').
For example, it is possible that you believe that the video is very desirable and rate it a
'5', but you think it is not as applicable to you and rate it a '2' but that it would be
acceptable to your peers and rate it a '4'.
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Desirable Score (1)

Applicable Score (2)

1. PART A:
Information about
tobacco use and
ADHD

2. PART B: Ask

3. PART B: Advise

4. PART B: Assess

5. PART B: Assist

6. PART B: Arrange

7. Overall use of the
animation video (7)

78

Acceptable Score (3)

Schizophrenia Face Validity
Dear Participant,
We would like your opinions about this video we have developed to train providers on
evidence-based tobacco treatment tailored to a patient/client living with Schizophrenia.
We would like you to rate the video on a scale of 0 to 5, based on how much you see it
as desirable, applicable, and acceptable to you and other providers caring for people
with schizophrenia.
Desirable = something you would want to hear/learn about
Applicable = something that is useful to you/you could use
Acceptable = something that would gain your interest/would make you seek more
information.
We would like you to please rate the different parts of the video that you just watched on
aspects of desirability, applicability and acceptability. Please use a scale of 0 to 5
(0 being 'not desirable/applicable/ acceptable' to 5 being 'very desirable/ applicable/
acceptable').
For example, it is possible that you believe that the video is very desirable and rate it a
'5', but you think it is not as applicable to you and rate it a '2' but that it would be
acceptable to your peers and rate it a '4'.
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Desirable Score (1)

Applicable Score (2)

1. PART A:
Information about
tobacco use and
schizophrenia

2. PART B: Ask

3. PART B: Advise

4. PART B: Assess

5. PART B: Assist

6. PART B: Arrange

7. Overall use of the
animation video (7)
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Acceptable Score (3)

